Sermorelin Acetate Lyophilized powder for reconstitution — Class II drug recall D-0718-2022
Terminated recall by Olympia Compounding Pharmacy dba Olympia Pharmacy, reported 2022-03-30, distributed nationwide. Sub Potent
| Recall number | D-0718-2022 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Olympia Compounding Pharmacy dba Olympia Pharmacy, Orlando, FL, United States |
| Recall initiated | 2022-03-08 |
| Classified | 2022-03-29 |
| Reported by FDA | 2022-03-30 |
| Terminated | 2023-10-04 |
| Distributed | Nationwide (US) |
| Quantity | 2,283 vials |
| NDC | 73198-0059-00 |
| Lot numbers | D44026, F42104 |
| Expiration dates | 2022-04-26, 2022-06-04 |
Product
Sermorelin Acetate Lyophilized powder for reconstitution, Multi-Dose 9 mg per vial, Each ML contains: 5% Mannitol USP, Sterile Water for Injection USP, Rx Only, Olympia Pharmaceuticals, 6700 Conroy Rd., Ste. 155, Orlando, FL 32835. NDC 73198-0059-00
Reason for recall
Sub Potent
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0718-2022. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.